Table of Contents
introduction
main indications
C/I
precautions
adverse effects
dose
acute ED Rx of SVT or hypertension
verapamil (Isoptin)
see also:
calcium channel blockers
calcium channel blocker overdose
introduction
a phenylalkylamine non-dihydropyridine
calcium blocking agent
acts mainly on arteriolar smooth muscle to reduce peripheral vascular resistance as well as having negative inotropic and AV conduction effects
main indications
supraventricular tachycardias (SVT)
C/I
BP < 90mmHg
the shocked hypotensive patient
bradycardia
sick sinus syndrome
AV block without a pacemaker
significant
left ventricular failure (LVF)
AF with
pre-excitation syndromes including WPW
(risk of
ventricular fibrillation (VF)
)
ventricular tachycardia (VT)
hypersensitivity
pregnancy - class C
precautions
concomitant
beta adrenergic blockers
risk AV blockade
liver impairment
grapefruit juice as this is an inhibitor of the CYP-3A4 enzyme and may cause toxicity of verapamil and other calcium channel blockers
lactation
adverse effects
hypotension
negative inotropic effect and cardiac failure risk
cardiac conduction blockade
peripheral oedema which is NOT responsive to
diuretics
which will only cause volume depletion
constipation
rarely, myasthenia-like neuromuscular disease
many possible drug interactions
dose
acute ED Rx of SVT or hypertension
3mg over 1-2min then 1mg per minute as needed up to 10mg max in adults